Daewoong pharmaceutical Co.,Ltd
KRX:069620.KS
142100 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,375,328.745 | 1,280,091.851 | 1,152,975.698 | 1,055,423.69 | 1,113,425.921 | 1,031,427.426 | 960,307.423 | 883,920.425 | 839,686.478 | 735,889.424 | 682,508.016 | 669,013.833 | 710,547.146 | 509,993.136 | 613,750.337 | 548,326.626 | 484,346.075 | 400,443.393 |
| Cost of Revenue
| 693,778.511 | 641,134.291 | 608,229.804 | 608,481.968 | 635,132.494 | 621,484.738 | 553,325.208 | 510,232.177 | 537,082.983 | 465,702.015 | 390,805.395 | 391,898.198 | 409,830.898 | 285,540.515 | 322,037.706 | 294,324.505 | 223,960.069 | 179,564.233 |
| Gross Profit
| 681,550.234 | 638,957.56 | 544,745.895 | 446,941.722 | 478,293.427 | 409,942.687 | 406,982.215 | 373,688.247 | 302,603.495 | 270,187.409 | 291,702.621 | 277,115.635 | 300,716.249 | 224,452.621 | 291,712.631 | 254,002.121 | 260,386.006 | 220,879.16 |
| Gross Profit Ratio
| 0.496 | 0.499 | 0.472 | 0.423 | 0.43 | 0.397 | 0.424 | 0.423 | 0.36 | 0.367 | 0.427 | 0.414 | 0.423 | 0.44 | 0.475 | 0.463 | 0.538 | 0.552 |
| Reseach & Development Expenses
| 171,573.444 | 163,601.58 | 127,269.068 | 115,217.59 | 109,440.5 | 113,811.779 | 107,938.832 | 103,691.022 | 31,068.178 | 18,742.574 | 21,169.522 | 19,643.106 | 19,519.569 | 4,311.709 | 10,298.112 | 3,271.534 | 7,071.961 | 5,828.152 |
| General & Administrative Expenses
| 14,188.731 | 20,411.327 | 19,145.985 | 19,046.662 | 24,210.76 | 26,999.884 | 26,480.212 | 28,750.864 | 26,373.306 | 25,559.46 | 28,206.171 | 24,932.304 | 26,423.099 | 16,569.413 | 35,138.449 | 42,400.741 | 30,853.765 | 26,779.947 |
| Selling & Marketing Expenses
| 211,163.121 | 225,004.92 | 196,054.443 | 188,701.171 | 191,033.099 | 140,898.581 | 118,654.377 | 102,841.437 | 93,641.665 | 82,282.245 | 74,327.875 | 87,770.426 | 90,827.672 | 67,143.316 | 87,217.863 | 81,260.098 | 75,889.757 | 63,493.47 |
| SG&A
| 384,476.988 | 245,416.247 | 215,200.428 | 207,747.833 | 215,243.859 | 167,898.465 | 145,134.589 | 131,592.301 | 120,014.971 | 107,841.705 | 102,534.046 | 112,702.73 | 117,250.771 | 83,712.729 | 122,356.312 | 123,660.839 | 106,743.522 | 90,273.417 |
| Other Expenses
| -4,382.055 | 134,142.584 | 113,374.222 | 106,996.574 | 108,921.971 | 3,637.073 | 8,849.829 | 4,509.572 | 3,302.861 | 989.809 | 4,613.267 | 4,517.774 | 1,605.581 | -6,717.291 | 6,367.704 | 5,202.702 | 2,864.365 | -6,362.229 |
| Operating Expenses
| 560,432.487 | 543,160.411 | 455,843.718 | 429,961.997 | 433,606.33 | 385,376.52 | 368,025.066 | 347,794.762 | 259,039.05 | 218,243.015 | 220,330.988 | 240,232.815 | 238,791.551 | 153,214.147 | 217,011.452 | 212,021.513 | 186,986.338 | 150,593.708 |
| Operating Income
| 121,117.747 | 57,099.657 | 27,606.078 | 16,979.724 | 44,687.097 | 24,566.168 | 38,957.149 | 25,893.485 | 43,564.445 | 51,944.394 | 71,371.633 | 36,882.819 | 63,630.246 | 71,238.477 | 74,701.179 | 41,980.605 | 73,399.664 | 70,285.454 |
| Operating Income Ratio
| 0.088 | 0.045 | 0.024 | 0.016 | 0.04 | 0.024 | 0.041 | 0.029 | 0.052 | 0.071 | 0.105 | 0.055 | 0.09 | 0.14 | 0.122 | 0.077 | 0.152 | 0.176 |
| Total Other Income Expenses Net
| 2,523.547 | -18,770 | -7,671.856 | -3,420.392 | -21,365.424 | -25,188.69 | -2,824.641 | 1,715.809 | 4,186.979 | 1,740.602 | 2,630.968 | 4,842.353 | 344.428 | -4,148.538 | -3,422.605 | 16,421.764 | 6,175.66 | -2,574.232 |
| Income Before Tax
| 123,641.295 | 38,329.657 | 19,934.222 | 13,559.333 | 23,321.673 | -622.522 | 36,132.508 | 27,609.294 | 47,751.423 | 53,684.996 | 74,002.601 | 41,725.172 | 63,974.674 | 67,089.939 | 71,278.574 | 44,382.134 | 79,575.324 | 67,711.222 |
| Income Before Tax Ratio
| 0.09 | 0.03 | 0.017 | 0.013 | 0.021 | -0.001 | 0.038 | 0.031 | 0.057 | 0.073 | 0.108 | 0.062 | 0.09 | 0.132 | 0.116 | 0.081 | 0.164 | 0.169 |
| Income Tax Expense
| 1,996.359 | -833.512 | -10,322.78 | -10,588.733 | -5,543.933 | 14,794.722 | 696.171 | 1,483.423 | 12,077.722 | 23,215.04 | 16,028.2 | 8,212.309 | 13,246.569 | 49,527.11 | 21,811.566 | 11,656.798 | 20,749.294 | 19,188.168 |
| Net Income
| 111,501.799 | 42,239.518 | 24,505.736 | 24,148.066 | 22,005.927 | -15,151.848 | 31,580.584 | 26,969.821 | 42,930.06 | 31,544.475 | 58,399.565 | 34,079.294 | 50,185.946 | 17,562.83 | 49,467.008 | 32,930.963 | 58,948.245 | 48,523.054 |
| Net Income Ratio
| 0.081 | 0.033 | 0.021 | 0.023 | 0.02 | -0.015 | 0.033 | 0.031 | 0.051 | 0.043 | 0.086 | 0.051 | 0.071 | 0.034 | 0.081 | 0.06 | 0.122 | 0.121 |
| EPS
| 10,656 | 3,815.95 | 2,226.87 | 2,264.77 | 2,132.18 | -1,468.08 | 3,060 | 2,613 | 4,160 | 3,056 | 5,658 | 3,302 | 4,998.06 | 1,677.82 | 4,663.56 | 3,064.39 | 5,411.14 | 4,433.64 |
| EPS Diluted
| 10,656 | 3,815.95 | 2,226.87 | 2,264.77 | 2,132.18 | -1,468 | 3,060 | 2,613 | 4,160 | 3,056 | 5,658 | 3,302 | 4,998.06 | 1,677.82 | 4,663.56 | 3,064.39 | 5,411.14 | 4,433.64 |
| EBITDA
| 163,818.424 | 96,794.321 | 68,489.519 | 60,942.385 | 84,744.92 | 82,626.134 | 87,121.797 | 61,162.541 | 74,822.702 | 73,305.807 | 96,993.61 | 62,654.96 | 88,291.302 | 79,818.216 | 113,281.819 | 39,916.359 | 87,425.726 | 78,023.465 |
| EBITDA Ratio
| 0.119 | 0.076 | 0.059 | 0.058 | 0.076 | 0.08 | 0.091 | 0.069 | 0.089 | 0.1 | 0.142 | 0.094 | 0.124 | 0.157 | 0.185 | 0.073 | 0.181 | 0.195 |